PTA Balloon Catheter Market Size, Share, Growth, Trends and Forecast Report, 2019 to 2026

by Susan Hill Business Consultant

The global PTA balloon catheter market size is expected to reach USD 5.1 billion by 2026, according to a new report by Grand View Research, Inc., registering a 10.1% CAGR over the forecast period. Expanding geriatric population base, increasing prevalence of cardiovascular diseases, presence of multi-national catheter manufacturers in regions like U.S., Europe, and Japan, and improving medical facilities are some of the key factors propelling the market.

Peripheral Vascular Disease (PVD) is a chronic disease in which plaque builds up in the blood vessels, thereby reducing blood flow to the organs and limbs. Angioplasty is the most common surgical method used for the treatment of peripheral vascular disease. The surgical process involves use of percutaneous transluminal angioplasty (PTA) balloon catheters, which widen the affected artery so as to facilitate and restore normal blood flow.

A study published in the PubMed Central (PMC) journal in 2018 states that more than 200 million people suffer from peripheral vascular disease across the globe, with the geriatric population being at the highest risk. According to the World Health Organization (WHO), the global aging population will rise from 12% in 2015 to 22% by 2050. Growing geriatric population is, therefore, anticipated to be a key factor boosting market growth. Studies suggest that obesity, kidney failure, diabetes, high triglycerides or cholesterol, high blood pressure, and smoking increase the risk for PVD. This is anticipated to increase the number of PVD-related surgeries, thereby propelling demand for PTA balloon catheter Market.

Rising number of medical device manufacturers is expected to fuel market growth. In addition, awareness about PTA balloon catheter among the population has in turn boosted the demand for its use. Increasing investments in R&D activities by manufacturers of medical devices and government funding is expected to drive the market. However, the major obstacle in the market is risk of infection associated with the use of PTA balloon catheter.

Further key findings from the report suggest:

Expanding geriatric population base, growing prevalence of peripheral vascular disease, and rise in preference for minimally invasive surgeries is propelling demand for PTA balloon catheter market
High prevalence of cardiovascular diseases in North America, coupled with increasing preference for minimally invasive surgeries among patients has enabled the region to emerge as the dominant regional segment in 2018
Asia Pacific is anticipated to register the fastest CAGR of 10.9% over the forecast period. Presence of a large patient pool, high unmet needs with regard to minimally invasive techniques, and rapid economic development are some of the major factors contributing to market growth
Some of the players operating in the market for PTA balloon catheter are Cardinal Health; Boston Scientific Corporation; Surmodics Inc.; Terumo Corporation; and Medtronic.